✨ Education and Health Notices




2 APRIL 2009 NEW ZEALAND GAZETTE, No. 46 1083

for Colwill School (as published in the New Zealand Gazette, 22 June 2006, No. 63, page 1504), and appoint

Trevor McKinlay

as commissioner.

All functions, powers and duties of the Board of Colwill School are vested in the commissioner.

This notice takes effect the day after the date of its publication.

Dated at Wellington this 31st day of March 2009.

KAREN SEWELL, Secretary for Education.

go2814

Amendment to Notice of Appointment of a Commissioner for Al-Madinah School (544)

Pursuant to section 78N(2) of the Education Act 1989, I hereby amend the notice of appointment of a commissioner for Al-Madinah School (as published in the New Zealand Gazette, 9 June 2005, No. 88, page 2089) and appoint

Christopher Saunders

as commissioner.

All functions, powers and duties of the board of Al-Madinah School are vested in the commissioner.

This notice takes effect the day after the date of publication.

Dated at Wellington this 31st day of March 2009.

KAREN SEWELL, Secretary for Education.

go2813

Health

Medicines Act 1981

Consent to the Distribution of a Changed Medicine

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the following new medicine which was referred to the Minister of Health under the provisions of section 24(5) of the Act and is set out in the Schedule hereto:

Schedule

Product: Mabthera
Active Ingredient: Rituximab 10mg/mL
Dosage Form: Concentrate for infusion
New Zealand Sponsor: Roche Products (New Zealand) Limited
Manufacturers: F Hoffmann-La Roche Limited, Basel, Switzerland
Genentech Inc, South San Francisco, California, United States of America
Roche Diagnostics GmbH, Germany

Dated this 30th day of March 2009.

JOHN HAZELDINE, Acting Deputy Director-General, Sector Accountability and Funding Directorate, Ministry of Health (pursuant to delegation given by the Minister of Health on 6 July 2001).

go2913

Consent to the Distribution of New Medicines

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:

Schedule

Product: Leflunomide Sandoz
Active Ingredient: Leflunomide 10mg
Dosage Form: Film coated tablet
New Zealand Sponsor: Novartis New Zealand Limited
Manufacturer: Cipla Limited, Manufacturing & Research Div., Virgonagar, Bangalore, India

Product: Leflunomide Sandoz
Active Ingredient: Leflunomide 20mg
Dosage Form: Film coated tablet
New Zealand Sponsor: Novartis New Zealand Limited
Manufacturer: Cipla Limited, Manufacturing & Research Div., Virgonagar, Bangalore, India

Product: Panadeine Caplets
Active Ingredients: Codeine phosphate, anhydrous 8mg
Paracetamol 500mg
Dosage Form: Tablet
New Zealand Sponsor: GlaxoSmithKline (NZ) Limited
Manufacturer: GlaxoSmithKline Australia Pty Limited, Consumer Healthcare, Ermington, New South Wales, Australia



Next Page →



Online Sources for this page:

Gazette.govt.nz PDF NZ Gazette 2009, No 46





✨ LLM interpretation of page content

πŸŽ“ Amendment to Notice of Appointment of a Commissioner for Colwill School (continued from previous page)

πŸŽ“ Education, Culture & Science
31 March 2009
Education Act, Colwill School, Commissioner Appointment
  • Trevor McKinlay, Appointed commissioner for Colwill School

  • KAREN SEWELL, Secretary for Education

πŸŽ“ Amendment to Notice of Appointment of a Commissioner for Al-Madinah School

πŸŽ“ Education, Culture & Science
31 March 2009
Education Act, Al-Madinah School, Commissioner Appointment
  • Christopher Saunders, Appointed commissioner for Al-Madinah School

  • KAREN SEWELL, Secretary for Education

πŸ₯ Consent to the Distribution of a Changed Medicine

πŸ₯ Health & Social Welfare
30 March 2009
Medicines Act, Mabthera, Rituximab, Roche Products
  • JOHN HAZELDINE, Acting Deputy Director-General, Sector Accountability and Funding Directorate, Ministry of Health

πŸ₯ Consent to the Distribution of New Medicines

πŸ₯ Health & Social Welfare
30 March 2009
Medicines Act, Leflunomide Sandoz, Panadeine Caplets, Novartis, GlaxoSmithKline
  • JOHN HAZELDINE, Acting Deputy Director-General, Sector Accountability and Funding Directorate, Ministry of Health